back to cluster viewer
cluster path 1011110000111
118 words, 8,459 tokens
freq alpha suffix
Words in frequency order
1 | promising | 8,270
|
2 | wake-promoting | 17
|
3 | commendable | 7
|
4 | gender-independent | 5
|
5 | paratransgenesis | 5
|
6 | pro-kinetic | 5
|
7 | disquieting | 4
|
8 | laminectomy-placed | 4
|
9 | pitied | 4
|
10 | 2-pronged | 3
|
11 | bio-control | 3
|
12 | cost-efficacious | 3
|
13 | antineoplasic | 2
|
14 | clinico-pedagogic | 2
|
15 | coadjutant | 2
|
16 | complete-detoxication | 2
|
17 | defectless | 2
|
18 | fdc-based | 2
|
19 | kt2000 | 2
|
20 | noncrossresistant | 2
|
21 | one-at-a-time | 2
|
22 | one-eyed | 2
|
23 | promissing | 2
|
24 | renal-sparing | 2
|
25 | resonable | 2
|
26 | scar-hidden | 2
|
27 | second-best | 2
|
28 | sequencing-phylogenetic | 2
|
29 | slower-acting | 2
|
30 | supelco | 2
|
31 | surface-accessible | 2
|
32 | systolic-blood-pressure | 2
|
33 | treat-all | 2
|
34 | vision-screening | 2
|
35 | watch-and-wait | 2
|
36 | 1.6λ-size | 1
|
37 | 25-km | 1
|
38 | 50,230 | 1
|
39 | 634-bp | 1
|
40 | 7053 | 1
|
41 | abuse/addictive | 1
|
42 | beta-blocker-led | 1
|
43 | bladder-ovary | 1
|
44 | blue-light-emitting | 1
|
45 | bsx-first | 1
|
46 | build/couple/pair | 1
|
47 | c20a3-reactive | 1
|
48 | categorical-qualitative | 1
|
49 | chip-cloning | 1
|
50 | chromosome-by-chromosome | 1
|
51 | class-five | 1
|
52 | cocooning | 1
|
53 | complications-preventive | 1
|
54 | conjugated/linked | 1
|
55 | copy-when-uncertain | 1
|
56 | cost-planning | 1
|
57 | counteradvertising | 1
|
58 | curating | 1
|
59 | decacyclic | 1
|
60 | double-focused | 1
|
61 | double-test | 1
|
62 | effective.further | 1
|
63 | exellent | 1
|
64 | ezrin-mediated | 1
|
65 | foldover | 1
|
66 | frequency-selective | 1
|
67 | genetic/pharmacogenetic | 1
|
68 | glycaemical | 1
|
69 | hit-and-run | 1
|
70 | human-validated | 1
|
71 | jupiter-based | 1
|
72 | keywording | 1
|
73 | legume-specific | 1
|
74 | lesions.this | 1
|
75 | loss-of-target | 1
|
76 | markers.these | 1
|
77 | multi-oncologic | 1
|
78 | multi-recruitment | 1
|
79 | n-glycosidase | 1
|
80 | no-salt | 1
|
81 | non-retrieval-based | 1
|
82 | nonaccommodative | 1
|
83 | nonmitogenic | 1
|
84 | nonsustainable | 1
|
85 | over-imposable | 1
|
86 | pan-arctic | 1
|
87 | passive-recruitment | 1
|
88 | photolabelling | 1
|
89 | policy-wide | 1
|
90 | polymorphism-dependent | 1
|
91 | pre-classification | 1
|
92 | pro-bioactive | 1
|
93 | promisingclinical | 1
|
94 | rare-symptom | 1
|
95 | relative-change | 1
|
96 | reynolds-averaging | 1
|
97 | risk-prevention | 1
|
98 | roundabout | 1
|
99 | rvot-sparing | 1
|
100 | sample-to-redundancy | 1
|
101 | scarce.physical | 1
|
102 | screw-in | 1
|
103 | semi-deep | 1
|
104 | sound-by-sound | 1
|
105 | speech-enhancement | 1
|
106 | straight-ahead | 1
|
107 | task-appropriate | 1
|
108 | therapeutical-based | 1
|
109 | thinkable | 1
|
110 | three-prong | 1
|
111 | transcerebellar | 1
|
112 | transesophageal-guided | 1
|
113 | tumournephrectomy | 1
|
114 | two-in-one | 1
|
115 | two-prong | 1
|
116 | unobjective | 1
|
117 | upto-date | 1
|
118 | v1-v6 | 1
|
Words in alphabetical order
1 | 1.6λ-size | 1
|
2 | 2-pronged | 3
|
3 | 25-km | 1
|
4 | 50,230 | 1
|
5 | 634-bp | 1
|
6 | 7053 | 1
|
7 | abuse/addictive | 1
|
8 | antineoplasic | 2
|
9 | beta-blocker-led | 1
|
10 | bio-control | 3
|
11 | bladder-ovary | 1
|
12 | blue-light-emitting | 1
|
13 | bsx-first | 1
|
14 | build/couple/pair | 1
|
15 | c20a3-reactive | 1
|
16 | categorical-qualitative | 1
|
17 | chip-cloning | 1
|
18 | chromosome-by-chromosome | 1
|
19 | class-five | 1
|
20 | clinico-pedagogic | 2
|
21 | coadjutant | 2
|
22 | cocooning | 1
|
23 | commendable | 7
|
24 | complete-detoxication | 2
|
25 | complications-preventive | 1
|
26 | conjugated/linked | 1
|
27 | copy-when-uncertain | 1
|
28 | cost-efficacious | 3
|
29 | cost-planning | 1
|
30 | counteradvertising | 1
|
31 | curating | 1
|
32 | decacyclic | 1
|
33 | defectless | 2
|
34 | disquieting | 4
|
35 | double-focused | 1
|
36 | double-test | 1
|
37 | effective.further | 1
|
38 | exellent | 1
|
39 | ezrin-mediated | 1
|
40 | fdc-based | 2
|
41 | foldover | 1
|
42 | frequency-selective | 1
|
43 | gender-independent | 5
|
44 | genetic/pharmacogenetic | 1
|
45 | glycaemical | 1
|
46 | hit-and-run | 1
|
47 | human-validated | 1
|
48 | jupiter-based | 1
|
49 | keywording | 1
|
50 | kt2000 | 2
|
51 | laminectomy-placed | 4
|
52 | legume-specific | 1
|
53 | lesions.this | 1
|
54 | loss-of-target | 1
|
55 | markers.these | 1
|
56 | multi-oncologic | 1
|
57 | multi-recruitment | 1
|
58 | n-glycosidase | 1
|
59 | no-salt | 1
|
60 | non-retrieval-based | 1
|
61 | nonaccommodative | 1
|
62 | noncrossresistant | 2
|
63 | nonmitogenic | 1
|
64 | nonsustainable | 1
|
65 | one-at-a-time | 2
|
66 | one-eyed | 2
|
67 | over-imposable | 1
|
68 | pan-arctic | 1
|
69 | paratransgenesis | 5
|
70 | passive-recruitment | 1
|
71 | photolabelling | 1
|
72 | pitied | 4
|
73 | policy-wide | 1
|
74 | polymorphism-dependent | 1
|
75 | pre-classification | 1
|
76 | pro-bioactive | 1
|
77 | pro-kinetic | 5
|
78 | promising | 8,270
|
79 | promisingclinical | 1
|
80 | promissing | 2
|
81 | rare-symptom | 1
|
82 | relative-change | 1
|
83 | renal-sparing | 2
|
84 | resonable | 2
|
85 | reynolds-averaging | 1
|
86 | risk-prevention | 1
|
87 | roundabout | 1
|
88 | rvot-sparing | 1
|
89 | sample-to-redundancy | 1
|
90 | scar-hidden | 2
|
91 | scarce.physical | 1
|
92 | screw-in | 1
|
93 | second-best | 2
|
94 | semi-deep | 1
|
95 | sequencing-phylogenetic | 2
|
96 | slower-acting | 2
|
97 | sound-by-sound | 1
|
98 | speech-enhancement | 1
|
99 | straight-ahead | 1
|
100 | supelco | 2
|
101 | surface-accessible | 2
|
102 | systolic-blood-pressure | 2
|
103 | task-appropriate | 1
|
104 | therapeutical-based | 1
|
105 | thinkable | 1
|
106 | three-prong | 1
|
107 | transcerebellar | 1
|
108 | transesophageal-guided | 1
|
109 | treat-all | 2
|
110 | tumournephrectomy | 1
|
111 | two-in-one | 1
|
112 | two-prong | 1
|
113 | unobjective | 1
|
114 | upto-date | 1
|
115 | v1-v6 | 1
|
116 | vision-screening | 2
|
117 | wake-promoting | 17
|
118 | watch-and-wait | 2
|
Words in suffix order
1 | kt2000 | 2
|
2 | 50,230 | 1
|
3 | 7053 | 1
|
4 | v1-v6 | 1
|
5 | legume-specific | 1
|
6 | clinico-pedagogic | 2
|
7 | multi-oncologic | 1
|
8 | decacyclic | 1
|
9 | nonmitogenic | 1
|
10 | antineoplasic | 2
|
11 | pan-arctic | 1
|
12 | genetic/pharmacogenetic | 1
|
13 | sequencing-phylogenetic | 2
|
14 | pro-kinetic | 5
|
15 | straight-ahead | 1
|
16 | laminectomy-placed | 4
|
17 | transesophageal-guided | 1
|
18 | 2-pronged | 3
|
19 | pitied | 4
|
20 | conjugated/linked | 1
|
21 | beta-blocker-led | 1
|
22 | fdc-based | 2
|
23 | therapeutical-based | 1
|
24 | non-retrieval-based | 1
|
25 | jupiter-based | 1
|
26 | double-focused | 1
|
27 | human-validated | 1
|
28 | ezrin-mediated | 1
|
29 | one-eyed | 2
|
30 | sound-by-sound | 1
|
31 | policy-wide | 1
|
32 | relative-change | 1
|
33 | commendable | 7
|
34 | thinkable | 1
|
35 | nonsustainable | 1
|
36 | resonable | 2
|
37 | over-imposable | 1
|
38 | surface-accessible | 2
|
39 | one-at-a-time | 2
|
40 | chromosome-by-chromosome | 1
|
41 | two-in-one | 1
|
42 | systolic-blood-pressure | 2
|
43 | n-glycosidase | 1
|
44 | markers.these | 1
|
45 | upto-date | 1
|
46 | task-appropriate | 1
|
47 | class-five | 1
|
48 | nonaccommodative | 1
|
49 | categorical-qualitative | 1
|
50 | c20a3-reactive | 1
|
51 | pro-bioactive | 1
|
52 | unobjective | 1
|
53 | frequency-selective | 1
|
54 | abuse/addictive | 1
|
55 | complications-preventive | 1
|
56 | 1.6λ-size | 1
|
57 | keywording | 1
|
58 | reynolds-averaging | 1
|
59 | photolabelling | 1
|
60 | vision-screening | 2
|
61 | cost-planning | 1
|
62 | chip-cloning | 1
|
63 | cocooning | 1
|
64 | renal-sparing | 2
|
65 | rvot-sparing | 1
|
66 | promising | 8,270
|
67 | counteradvertising | 1
|
68 | promissing | 2
|
69 | curating | 1
|
70 | slower-acting | 2
|
71 | disquieting | 4
|
72 | wake-promoting | 17
|
73 | blue-light-emitting | 1
|
74 | three-prong | 1
|
75 | two-prong | 1
|
76 | glycaemical | 1
|
77 | promisingclinical | 1
|
78 | scarce.physical | 1
|
79 | treat-all | 2
|
80 | bio-control | 3
|
81 | 25-km | 1
|
82 | rare-symptom | 1
|
83 | scar-hidden | 2
|
84 | screw-in | 1
|
85 | copy-when-uncertain | 1
|
86 | pre-classification | 1
|
87 | complete-detoxication | 2
|
88 | risk-prevention | 1
|
89 | hit-and-run | 1
|
90 | supelco | 2
|
91 | 634-bp | 1
|
92 | semi-deep | 1
|
93 | transcerebellar | 1
|
94 | effective.further | 1
|
95 | foldover | 1
|
96 | build/couple/pair | 1
|
97 | lesions.this | 1
|
98 | paratransgenesis | 5
|
99 | defectless | 2
|
100 | cost-efficacious | 3
|
101 | loss-of-target | 1
|
102 | watch-and-wait | 2
|
103 | no-salt | 1
|
104 | noncrossresistant | 2
|
105 | coadjutant | 2
|
106 | polymorphism-dependent | 1
|
107 | gender-independent | 5
|
108 | exellent | 1
|
109 | speech-enhancement | 1
|
110 | passive-recruitment | 1
|
111 | multi-recruitment | 1
|
112 | second-best | 2
|
113 | double-test | 1
|
114 | bsx-first | 1
|
115 | roundabout | 1
|
116 | sample-to-redundancy | 1
|
117 | tumournephrectomy | 1
|
118 | bladder-ovary | 1
|